A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell
DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 201–300 of 999

  1. Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
    Guangshun Sun, Zhouxiao Li, Dawei Rong, Hao Zhang, Xuesong Shi, Weijun Yang, Wubin Zheng, Guoqiang Sun, Fan Wu, Hongyong Cao et al. · 2021 · Molecular Therapy — Oncolytics
  2. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
    Claudia Capparelli, Timothy J. Purwin, McKenna Q. Glasheen, Signe Caksa, Manoela Tiago, Nicole A. Wilski, Danielle Pomante, Sheera R. Rosenbaum, Mai Q. Nguyen, Weijia Cai et al. · 2022 · Nature Communications
  3. ZEB1 transcription factor promotes immune escape in melanoma
    Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon, Jonathan Lopez, Myrtille Le Bouar, B. Balme, Garance Tondeur, Arnaud de la Fouchardière et al. · 2022 · Journal for ImmunoTherapy of Cancer
  4. Single‐cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug‐resistance in lung adenocarcinoma
    Lei He, Yixian Fan, Yue Zhang, Tong-Tao Tu, Quan Zhang, Fahu Yuan, Chao Cheng · 2022 · Journal of Pineal Research
  5. Evaluation of single-cell classifiers for single-cell RNA sequencing data sets
    Xinlei Shelly Zhao, Shuang Wu, Nan Fang, Xiao Song Sun, Jue Fan · 2019 · Briefings in Bioinformatics
  6. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy
    Liwei Jiang, Yi‐Jun Wang, Jing Zhao, Mayuko Uehara, Qingming Hou, Vivek Kasinath, Takaharu Ichimura, Naima Banouni, Li Dai, Xiaofei Li et al. · 2020 · Cell
  7. The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
    Patricia Ho, Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah, Zachary H. Walsh, Oleksandr Kyrysyuk, Amit Dipak Amin, Lindsay Caprio et al. · 2023 · Cancer Cell
  8. Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma
    David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Alizée J Grimm, Matteo Morotti et al. · 2024 · Science Immunology
  9. CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
    Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev, Jared Weiss, Taofeek Kunle Owonikoko, Julie A. Rytlewski, Jill Van Wart Hood, Yang Zhao, Rajesh K. Malik, Jay C. Strum et al. · 2020 · Journal for ImmunoTherapy of Cancer
  10. Cytotoxic T cells swarm by homotypic chemokine signalling
    Jorge Luis Galeano Niño, Sophie V. Pageon, Szun S. Tay, Feyza Colakoglu, Daryan Kempe, Jack D. Hywood, Jessica K. Mazalo, James Cremasco, Matt Govendir, Laura F. Dagley et al. · 2020 · eLife
  11. Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
    Satyaki Sengupta, Sanjukta Das, Ângela C. Crespo, Annelisa M. Cornel, Anand G. Patel, Navin R. Mahadevan, Marco Campisi, Alaa Kassim Ali, Bandana Sharma, Jared H. Rowe et al. · 2022 · Nature Cancer
  12. Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications
    Min‐Ying Su, Tao Pan, Qiu-Zhen Chen, Weiwei Zhou, Yi Gong, Gang Xu, Huan-Yu Yan, Si Li, Qiao-Zhen Shi, Ya Zhang et al. · 2022 · Military Medical Research
  13. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
    Yaqi Tang, Simon Durand, Stéphane Dalle, Julie Caramel · 2020 · Cancers
  14. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
    Lisa Cucolo, Qingzhou Chen, Jingya Qiu, Yongjun Yu, Max Klapholz, Krista A. Budinich, Zhaojun Zhang, Yue Shao, Igor E. Brodsky, Martha S. Jordan et al. · 2022 · Immunity
  15. Chromatin basis of the senescence-associated secretory phenotype
    Hao, Xue, Wang, Chen, Zhang, Rugang · 2022 · Trends in Cell Biology
  16. Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
    Yanna Lei, Xiaoying Li, Qian Huang, Xiufeng Zheng, Ming Liu · 2021 · Frontiers in Oncology
  17. Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
    Michal Sheffer, Emily Lowry, Nicky A. Beelen, Minasri Borah, Suha Naffar-Abu Amara, Chris C. Mader, Jennifer A. Roth, Aviad Tsherniak, Samuel S. Freeman, Olga Dashevsky et al. · 2021 · Nature Genetics
  18. scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets
    Massimo Andreatta, Ariel José Berenstein, Santiago J. Carmona · 2022 · Bioinformatics
  19. Combinatorial prediction of marker panels from single‐cell transcriptomic data
    Conor Delaney, Alexandra Schnell, Louis V. Cammarata, Aaron Yao-Smith, Aviv Regev, Vijay Kumar Kuchroo, Meromit Singer · 2019 · Molecular Systems Biology
  20. Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
    Robert John Walsh, Ross Andrew Soo · 2020 · Therapeutic Advances in Medical Oncology
  21. Neutrophils Extracellular Traps Inhibition Improves PD-1 Blockade Immunotherapy in Colorectal Cancer
    Hongji Zhang, Yu Wang, Amblessed E. Onuma, Jiayi He, Han Wang, Yujia Xia, Rhea Lal, Xiang Cheng, Gyulnara G. Kasumova, Zhiwei Hu et al. · 2021 · Cancers
  22. Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma
    Inger Z. M. Kreuger, Roderick C. Slieker, Tim van Groningen, Remco van Doorn · 2022 · Journal of Investigative Dermatology
  23. Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer
    Christine Y. Yeh, Karmen Aguirre, Olivia Laveroni, Subin Kim, Aihui Wang, Brooke Liang, Xiaoming Zhang, Lucy M. Han, Raeline Valbuena, Michael Cory Bassik et al. · 2024 · Nature Immunology
  24. Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation
    Nathaniel R. Campbell, Anjali N. Rao, Miranda Hunter, Magdalena K. Sznurkowska, Luzia Briker, Maomao Zhang, Maayan Baron, Silja Heilmann, Maxime Déforet, Colin Kenny et al. · 2021 · Developmental Cell
  25. Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms
    Leire Bejarano, Annamaria Kauzlaric, Eleni Lamprou, João Lourenço, Nadine Fournier, Michelle Ballabio, Roberto Colotti, Roeltje R. Maas, Sabine Galland, Matteo Massara et al. · 2024 · Cancer Cell
  26. Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types
    Junho Kang, Jun Hyeong Lee, Hongui Cha, Jinhyeon An, Joonha Kwon, SeongWoo Lee, Seongryong Kim, Mert Yakup Baykan, So Yeon Kim, Dohyeon An et al. · 2024 · Nature Communications
  27. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy
    Camelia Y. J. Quek, Aditya Pratapa, Xinyu Bai, Ghamdan Al‐Eryani, Inês Pires da Silva, Aaron T. Mayer, Nenad Bartoniček, Kate Harvey, Nigel Gordon Maher, Jordan W. Conway et al. · 2024 · Cell Reports
  28. The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
    Niels Vandamme, Geertrui Denecker, Kenneth Bruneel, Gillian Blancke, Özden Akay, Joachim Taminau, Jordy De Coninck, Eva De Smedt, Nicolas Skrypek, Wouter Van Loocke et al. · 2020 · Cancer Research
  29. Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity
    Yingjiao Cao, Yu Li, Xiangyang Wang, Shaorui Liu, Yongmei Zhang, Gaoyu Liu, Shusen Ye, Yuhao Zheng, Jiacong Zhao, Xiaodong Zhu et al. · 2023 · Immunity
  30. Pan-cancer classification of single cells in the tumour microenvironment
    Ido Nofech-Mozes, David M. Soave, Philip Awadalla, Sagi Abelson · 2023 · Nature Communications
  31. Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
    Nathaniel D. Anderson, Jack Birch, Théo Accogli, Ignacio Criado, Eleonora Khabirova, Conor Parks, Yvette Wood, Matthew D. Young, Tarryn Porter, Rachel Richardson et al. · 2023 · Nature Medicine
  32. T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
    Wenhui Yang, Shimao Liu, Mengyun Mao, Yandong Gong, Xiaohui Li, Tianyu Lei, Chao Liu, Shikai Wu, Qinyong Hu · 2024 · Journal of Experimental & Clinical Cancer Research
  33. Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors
    Adam Christopher Palmer, Benjamin Izar, Haeun Hwangbo, Peter Karl Sorger · 2022 · Clinical Cancer Research
  34. Single-cell RNA sequencing reveals distinct immunology profiles in human keloid
    Cheng Feng, Mengjie Shan, Yijun Xia, Zhi Zheng, Kai He, Yingxin Wei, Kexin Song, Tian Meng, Hao Liu, Yan Hao et al. · 2022 · Frontiers in Immunology
  35. Leveraging big data of immune checkpoint blockade response identifies novel potential targets
    Yacine Barèche, Deirdre Kelly, Farnoosh Abbas Aghababazadeh, M. Nakano, Parinaz Nasr Esfahani, Douglas Tkachuk, H. Mohammad, Robert M. Samstein, Chung‐Han Lee, Luc G.T. Morris et al. · 2022 · Annals of Oncology
  36. Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy
    Chuan Liu, Jindong Xie, Bo Lin, Weihong Tian, Yifan Wu, Xin Shan, Libing Hong, Xin Li, Lulu Liu, Yuzhi Jin et al. · 2024 · Advanced Science
  37. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
    Amy Li, Rebecca H. Herbst, David A. Canner, Jason M. Schenkel, Olivia C. Ghirardelli Smith, Jonathan Y. Kim, Michelle Hillman, Arjun J. Bhutkar, Michael S. Cuoco, C. Garrett Rappazzo et al. · 2019 · Cell Reports
  38. Single-cell analysis reveals immune landscape in kidneys of patients with chronic transplant rejection
    Yongguang Liu, Jianmin Hu, Ding Liu, Song Zhou, Jun Liao, Guorong Liao, Siqiang Yang, Zefeng Guo, Yuzhu Li, Shichao Li et al. · 2020 · Theranostics
  39. Molecular patterns of resistance to immune checkpoint blockade in melanoma
    Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila K. Kaminska, Anna Ebbesson, Ingrid A. Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar et al. · 2024 · Nature Communications
  40. Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes
    Haonan Zhang, Ge Zhang, Pengyuan Xu, Fengyi Yu, Liwen Li, Runzhi Huang, Zhenfa Zhang, Kaisaierjiang Kadier, Yuanyuan Wang, Qiqi Gu et al. · 2025 · Med Research
  41. A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
    Stephen Lam Chan, Martin Schüler, Yoon‐Koo Kang, Chia‐Jui Yen, Julien Edeline, Su Pin Choo, Chia‐Chi Lin, Takuji Okusaka, Karl-Heinz Weiss, Teresa Mercade Macarulla et al. · 2022 · Journal of Experimental & Clinical Cancer Research
  42. Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy
    Mei Lu, Haonan Xing, Wanxuan Shao, Tian Zhang, Mengjie Zhang, Yongchao Wang, Fangzhou Li, Yuhua Weng, Aiping Zheng, Yuanyu Huang et al. · 2022 · Advanced Materials
  43. Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
    Yefang Lao, Daoming Shen, Weili Zhang, Rui He, Min Jiang · 2022 · Cancers
  44. Single-cell sequencing and its applications in head and neck cancer
    Zongtai Qi, Thomas F. Barrett, Anuraag S. Parikh, Itay Tirosh, Sidharth V. Puram · 2019 · Oral Oncology
  45. Immunology in the Era of Single-Cell Technologies
    Mirjana Efremova, Roser Vento‐Tormo, Jong-Eun Park, Sarah Amalia Teichmann, Kylie Renee James · 2020 · Annual Review of Immunology
  46. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
    Georgia Marie Beasley, Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin‐Ho Jung, Darell D. Bigner, Andrea True Kelly, Matthias Gromeier et al. · 2021 · Journal for ImmunoTherapy of Cancer
  47. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
    Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, Apostolos Menegakis, Maaike van Zon, Andrew J. Morris, Jan Köster, Fernando Salgado-Polo, Sander de Kivit, Telma Lança et al. · 2021 · Cell Reports
  48. Bridging live-cell imaging and next-generation cancer treatment
    María Alieva, Amber K. L. Wezenaar, Ellen J. Wehrens, Anne C. Rios · 2023 · Nature reviews. Cancer
  49. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
    Antonino Glaviano, Seth Andrew Wander, Richard D. Baird, Kenneth Chun-Yong Yap, Hiu Yan Lam, Masakazu Toi, Daniela Carbone, Birgit Geoerger, Violeta Serra, Robert H. Jones et al. · 2024 · Drug Resistance Updates
  50. Single-cell omics: experimental workflow, data analyses and applications
    Fengying Sun, Haoyan Li, Dongqing Sun, Shaliu Fu, Lei Gu, Xin Shao, Qinqin Wang, Xin Dong, Bin Duan, Feiyang Xing et al. · 2024 · Science China Life Sciences
  51. Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types
    Răzvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, Andrew V Albright, Julie Kobie, Lingkang Huang, Qing Zhao, Anran Wang, Hua Ma, Zhu Alexander Cao et al. · 2021 · Clinical Cancer Research
  52. Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape
    Ren, Jingyi, Zhou, Haowen, Zeng, Hu, Wang, Connie Kangni, Huang, Jiahao, Qiu, Xiaojie, Sui, Xin, Li, Qiang, Wu, Xunwei, Lin, Zuwan et al. · 2023 · Nature Methods
  53. Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
    Housaiyin Li, Dan Paul Zandberg, Aditi Kulkarni, Simion I. Chiosea, Patricia M. Santos, Brian Robert Isett, Marion Joy, Gabriel Sica, Kevin J. Contrera, Curtis M. Tatsuoka et al. · 2025 · Cancer Cell
  54. The Role of Immune Checkpoint Blockade in Uveal Melanoma
    Anja Wessely, Theresa Steeb, Michael Erdmann, Lucie Heinzerling, Julio Vera, Max S. Schlaak, Carola Berking, Markus Vincent Heppt · 2020 · International Journal of Molecular Sciences
  55. MITF controls the TCA cycle to modulate the melanoma hypoxia response
    Pakavarin Louphrasitthiphol, Ioanna Ledaki, Jagat Singh Chauhan, Paola Falletta, Robert Siddaway, Francesca Meteora Buffa, David Robert Mole, Tomoyoshi Soga, Colin R. Goding · 2019 · Pigment Cell & Melanoma Research
  56. PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy
    Sylvain Simon, Valentin Voillet, Virginie Vignard, Zhong Wu, Camille Dabrowski, Nicolas Jouand, Tiffany Beauvais, Amir Khammari, Cécile Braudeau, Régis Josien et al. · 2020 · Journal for ImmunoTherapy of Cancer
  57. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
    Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David Ast, Alena Heimsoeth, Takamasa Nakasuka et al. · 2021 · Nature Communications
  58. Future Challenges in Cancer Resistance to Immunotherapy
    Marit J van Elsas, Thorbald van Hall, Sjoerd H. van der Burg · 2020 · Cancers
  59. DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden
    David Hsiehchen, Antony Hsieh, Robert M. Samstein, Tianshi Lu, Muhammad Shaalan Beg, David E. Gerber, Tao Wang, Luc G.T. Morris, Hao Zhu · 2020 · Cell Reports Medicine
  60. Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes
    Yasmin Kamal, Stephanie L. Schmit, Hannah J. Hoehn, Christopher Ian Amos, Hildreth Robert Frost · 2019 · Cancer Research
  61. Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
    Massimo Saini, Barbara Maria Szczerba, Nicola Aceto · 2019 · Cancer Research
  62. A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
    Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel N. Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus Peter Heußel, Felix J.F. Herth, Hauke Winter et al. · 2021 · OncoImmunology
  63. Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
    Gang Xin, Chen Yao, Paytsar Topchyan, Moujtaba Y. Kasmani, Robert Burns, Peter J. Volberding, Xiaopeng Wu, Alexandra Cohn, Yiliang Chen, Chien‐Wei Lin et al. · 2021 · Cancer Immunology Research
  64. Trends and Potential of Machine Learning and Deep Learning in Drug Study at Single-Cell Level
    Ren Qi, Quan Zou · 2023 · Research
  65. Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response–related genes
    Ke-Yue Ma, Alexandra A. Schonnesen, Amy Brock, Carla Van Den Berg, S. Gail Eckhardt, Zhihua Liu, Ning Jenny Jiang · 2019 · JCI Insight
  66. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation
    Wei Yin, Yihong Li, Yan Y. Song, Jiarui Zhang, Chao Wu, Yu Chen, Ying Miao, Changdong Lin, Yuli Lin, Dapeng Yan et al. · 2021 · Proceedings of the National Academy of Sciences
  67. CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
    Mattia Garutti, Giada Targato, Silvia Buriolla, Lorenza Palmero, Alessandro Marco Minisini, Fabio Puglisi · 2021 · Cells
  68. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination
    Éléonore De Guillebon, Antoine Dardenne, Antonin Saldmann, Sylvie Séguier, Thi Tran, Léa Paolini, Célèste Lebbé, Éric Tartour · 2020 · International Journal of Cancer
  69. Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing
    Rishikesh Kumar Gupta, Jacek Kuźnicki · 2020 · Cells
  70. Metabolic regulation of the cancer-immunity cycle
    Luis F. Somarribas Patterson, Santosha Adipudi Vardhana · 2021 · Trends in Immunology
  71. Advances in and prospects of immunotherapy for prostate cancer
    Deng Liu, Luofu Wang, Yanli Guo · 2024 · Cancer Letters
  72. Immunomodulatory Roles of Cell Cycle Regulators
    Laphanuwat, Phatthamon, Jirawatnotai, Siwanon · 2019 · Frontiers in Cell and Developmental Biology
  73. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq
    Santiago J. Carmona, Imran Siddiqui, Mariia Bilous, Werner Held, David Gfeller · 2020 · OncoImmunology
  74. Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma
    Pablo Álvarez Ballesteros, Jesús Chamorro, María San Román, Javier Pozas, Victoria Gómez Dos Santos, Álvaro Ruiz Granados, Enrique Grande, Teresa Alonso‐Gordoa, Javier Molina‐Cerrillo · 2021 · Cancers
  75. Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion
    Laure Tillé, Daniela Cropp, Mélanie Charmoy, Patrick Reichenbach, Massimo Andreatta, Tania Wyss, Gabrielle Bodley, Isaac Crespo, Sina Nassiri, João Lourenço et al. · 2023 · Nature Immunology
  76. Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy
    Yash Chhabra, Mitchell E. Fane, Sneha Pramod, Laura Hüser, Daniel J. Zabransky, Vania Wang, Agrani Dixit, Ruzhang Zhao, Edwin Kumah, Megan L. Brezka et al. · 2024 · Cell
  77. CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy
    Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Lijuan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang et al. · 2023 · Nature Communications
  78. Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies
    Marc C. Pulanco, Anne Tranberg Madsen, Ankit Tanwar, Devin T. Corrigan, Xingxing Zang · 2023 · Cellular and Molecular Immunology
  79. Immunotherapy for skin cancer
    Kelly Garneski Paulson, Miranda C. Lahman, Aude G. Chapuis, Isaac Brownell · 2019 · International Immunology
  80. High-dimensional immune-profiling in cancer: implications for immunotherapy
    Samuel Chuah, Valerie Chew · 2020 · Journal for ImmunoTherapy of Cancer
  81. Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
    Rachael M. Zemek, Wee Loong Chin, Anna K. Nowak, Michael Millward, Richard Lake, Willem Joost Lesterhuis · 2020 · Frontiers in Immunology
  82. Single-Cell Techniques and Deep Learning in Predicting Drug Response
    Zhenyu Wu, Patrick J. Lawrence, Anjun Ma, Jian Zhu, Dong Xu, Qin Ma · 2020 · Trends in Pharmacological Sciences
  83. Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
    Shaojun Zhang, Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Qingsong Cai, Rongjia Zhang, Joseph Mitchell McIntosh, Ruiping Wang et al. · 2021 · Nature Communications
  84. LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
    Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández‐Prat, David Casadevall, Sílvia Menéndez, Daniel Dan Liu et al. · 2022 · Nature Cancer
  85. Cancer biology deciphered by single-cell transcriptomic sequencing
    Yanmeng Li, Jianshi Jin, Fan Bai · 2021 · Protein & Cell
  86. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers
    Olli Dufva, Sara Gandolfi, Jani Huuhtanen, Olga Dashevsky, Hanna Duàn, Khalid Saeed, Jay Klievink, Petra Johanna Nygren, Jonas Bouhlal, Jenni Lahtela et al. · 2023 · Immunity
  87. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
    James T. Yurkovich, Qiang Tian, Nathan D. Price, Leroy Hood · 2019 · Nature Reviews Clinical Oncology
  88. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
    Yao Yao, Zhongyi Yan, Senlin Lian, Liangnian Wei, Chao Hui ZHOU, Dongju Feng, Yuan Zhang, Jianrong Yang, Ming Li, Yun Chen · 2020 · Journal for ImmunoTherapy of Cancer
  89. Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
    Sridhar Nimmagadda · 2020 · Cancers
  90. Single-Cell Analysis of the Pan-Cancer Immune Microenvironment and scTIME Portal
    Fang Hong, Qianqian Meng, Weiyu Zhang, Ruiqin Zheng, Xiaoyun Li, Tao Cheng, Deqing Hu, Xin Gao · 2021 · Cancer Immunology Research
  91. Urine Single-Cell RNA Sequencing in Focal Segmental Glomerulosclerosis Reveals Inflammatory Signatures
    Khun Zaw Latt, Jürgen A. W. Heymann, Joseph H. Jessee, Avi Z. Rosenberg, Céline C. Berthier, Arnon Arazi, Sean F. Eddy, Teruhiko Yoshida, Yongmei Zhao, Vicky Chen et al. · 2021 · Kidney International Reports
  92. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
    Elcheva, Irina A., Gowda, Chethana P., Bogush, Daniel, Gornostaeva, Svetlana, Fakhardo, Anna, Sheth, Neil, Kokolus, Kathleen M., Sharma, Arati, Dovat, Sinisa, Uzun, Yasin et al. · 2023 · Frontiers in Immunology
  93. Cross-tissue multicellular coordination and its rewiring in cancer
    Qiang Shi, Yihan Chen, Yang Li, Shishang Qin, Yu Yang, Yang Gao, Linnan Zhu, Dongfang Wang, Zemin Zhang · 2025 · Nature
  94. A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors
    Michal Slyper, Caroline B. M. Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Christopher S. Smillie, Gabriela Smith-Rosario, Jingyi Wu, Danielle Ashley Dionne et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications
    Binghao Zhao, Bo Chang Wu, Nan Feng, Xiang Zhang, Xin Zhang, Yiping Wei, Wenxiong Zhang · 2023 · Journal of Hematology & Oncology
  96. Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
    Yue Liu, Isabelle Lomeli, Stephen J. Kron · 2024 · Cells
  97. Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype
    Hao Xue, Bo Zhao, Wei Zhou, Heng Liu, Takeshi Fukumoto, Dmitry I. Gabrilovich, Rugang Zhang · 2020 · iScience
  98. Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
    Eran Hodis, Elena Torlai Triglia, John Kwon, Tommaso Biancalani, Labib R. Zakka, Saurabh Parkar, Jan-Christian Hütter, Lorenzo Buffoni, Toni Marie Delorey, Devan Phillips et al. · 2022 · Science
  99. MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
    Renumathy Dhanasekaran, Aida S. Hansen, Jangho Park, Lea Lemaitre, Ian K. Lai, Nia Adeniji, Sibu P. Kuruvilla, Akanksha Suresh, Josephine Zhang, Varsha Swamy et al. · 2022 · Cancer Research
  100. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
    Yahaya Abubakar Yabo, Pilar M. Moreno‐Sanchez, Yolanda Pires‐Afonso, Tony Kaoma, Bakhtiyor Nosirov, Andrea Scafidi, Luca Ermini, Anuja Lipsa, Anaïs Oudin, Dimitrios Kyriakis et al. · 2024 · Genome Medicine